Stocks and InvestingStocks and Investing
Thu, October 22, 2020
Wed, October 21, 2020
Tue, October 20, 2020
Mon, October 19, 2020

Salveen Richter Initiated (TSHA) at Strong Buy and Held Target at $31 on, Oct 19th, 2020


Published on 2024-10-27 14:24:10 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $31 on, Oct 19th, 2020.

Salveen, nor any peers, have made any analyst calls on TSHA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30